Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines

Endocrinology

Volumn 137, Issue 10, 1996, Pages 4322-4330

  Saceda, Miguel ^a   Grunt, Thomas W ^a,b   Colomer, Ramon ^a   Lippman, Marc E ^a   Lupu, Ruth ^a   Martin, Mary Beth ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER SURVIVAL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; TREATMENT OUTCOME;

EID: 0029761507     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.10.8828492     Document Type: Article

References (44)

1. Lippman ME, Dickson RB 1989 Mechanisms of growth control in normal and malignant breast epithelial. Recent Prog Horm Res 45:383-440
2. Davis RJ 1993 The mitogen-activated protein kinase signal transduction pathways. J Biol Chem 268:14553-14556
3. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K 1986 Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature 319:230-234
4. Schechter AL, Stern DF, Vaidyanathan L 1984 An erbB related gene encoding a 185,000-Mr tumor antigen. Nature 312:513-516
5. Semba K, Kamata N, Toyoshima K, Yamamoto T 1985 v-erbB related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Aci USA 82:6497-6501
6. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF 1988 Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712
7. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL 1987 Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182
8. Borg A, Baldetorp B, Ferno M, Killander D, Olsson H, Sigurdsson H 1991 ErbB2 amplification in breast cancer with a high rate of proliferation. Oncogene 6:137-143
9. Nicholson S, Wright C, Sainsbury RC, Halcrow P, Kelly P, Angus B, Farndon JR, Harris AL 1990 Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failure. J Steroid Biochem Mol Biol 37:811-814
10. Wiltschke C, Tyl E, Steininger A, Zielinski C, Spona J, Zeilinger R, Kury F, Czerwenka K, Kubista E, Speiser P, Preis P 1991 Increased NK-cell activity correlates with low or negative expression of the HER-2/neu oncogene in breast cancer patients. Proc Am Assoc Cancer Res 32:203-203
11. Leitzel K, Teramoto Y, Konrad K, Chinchilli VM, Volas G, Grossberg H, Harvey H, Demers L, Lipton A 1995 Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer. J Clin Oncol 13:1129-1135
12. Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, Todara GJ, Shoyab M 1990 Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci USA 87:4905-4090
13. Plowman GD, Culouscou JM, Whitney GS, Green JM, Carlton GW, Foy L, Neubauer MG, Shoyab M 1993 Liquid-specific activation of HER4/ p180erbB4, a fourth member ot the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90:1746-1750
14. Lemoine NR, Barnes DM, Hollywood DP, Huges CM, Smith P, Dublin E, Prigent SA, Gullick WJ, Hurst HC 1992 Expression of the ERBB-3 gene product in breast cancer. Br J Cancer 66:1116-1121
15. Lupu R, Wellstein A, Sheridan J, Ennis BW, Zugmaier G, Katz D, Lippman ME, Dickson RB 1992 Purification and characterization of a novel growth factor from human breast cancer cells. Biochem 31:7330-7340
16. Lupu R, Colomer R, Zugmaier G, Shepard M, Slamon D, Lippman ME 1990 Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2. Science 249:1552-1555
17. Lupu R, Colomer R, Kannan B, Lippman ME 1992 Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses. Proc Natl Acad Sci USA 89:2287-2291
18. Wen D, Peles E, Cupples R, Suggs SV, Bacus SS, Luo Y, Trail G, Hu S, Silbiger SM, Ben-Levy R, Koski RA, Lu HS, Yarden Y 1992 Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 69:559-572
19. Falls DL, Rosen KM, Corfas G, Lane WS, Fischbach GD 1993 ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell 72:801-815
20. Marchionni MA, Goodearl ADJ, Chen MS, Bermingham-McDonogh O, Kirk C, Hendricks M, Danehy F, Misumi D, Sudhalter J, Kobayashi K, Wroblewski D, Lynch C, Baldassare M, Hiles I, Davis JB, Hsuan JJ, Totty NF, Otsu M, McBurney RN, Waterfield MD, Stroobant P, Gwynne D 1993 Glial growth factors are alternatively spliced erbB-2 ligands expressed in the nervous system. Nature 362:312-318
21. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, Shepard HM, Kuang WJ, Goeddel DV, Vandlen RL 1992 Identification of heregulin, a specific activator of p185erbB2. Science 256:1205-1210
22. Richter A, Sanford KK, Evans VJ 1972 Influence of oxygen and culture media on plating efficiency of some mammalian tissue cells. J Natl Cancer Inst 49:1705-1712
23. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS 1986 Phenol red in tissue culture is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83:2496-2500
24. Darbre P, Yates J, Curtis S, King RJB 1983 Effect of estradiol on human breast cancer cells in culture. Cancer Res 43:349-354
25. Saceda M, Lippman ME, Chambon P, Lindsey RK, Puente M, Martin MB 1988 Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 2:1157-1162
26. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P 1990 Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptors forms A and B. EMBO J 9:1603-1614
27. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P 1982 Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast cancer cell line. Nucleic Acids Res 10:7895-7903
28. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanante-phenol-chloroform extraction. Anal Biochem 162:156-159
29. Laborda J 1991 36B4 cDNA used as an estradiol-independent messenger RNA control is the cDNA for human acidic ribosomal phosphoprotein P0. Nucleic Acids Res 19:3998
30. Saceda M, Knabbe C, Dickson RB, Lippman ME, Bronzert D, Lindsey RK, Gottardis MM, Martin MB 1991 Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-o-tetradecanoylphorbol-13-acetate. J Biol Chem 266:17809-17814
31. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K 1989 Current Protocols in Molecular Biology. Greene Publishing Assoc, New York
32. Klein-Hitpass L, Schorpp M, Wagner U, Ryffel GU 1986 An estrogen-responsive element derived from the 5′flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46:1053-1061
33. Chen C, Okayama H 1987 High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752
34. Hirt B 1967 Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26:365-369
35. Filmus J, Pollak MN, Cailleau R, Buick RN 1985 MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptor, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem Biophys Res Commun 128:898-905
36. Kato S, Tora L, Yamauchi J, Massushige S, Bellard M, Chambon P 1992 A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5′-TGACC-3′ motifs acting synergistically. Cell 68:731-742
37. Wright C, Nicholson S, Angus B, Sainburg JRC, Farndon J, Cairns J, Harris AL, Home CHW 1992 Relationship between erbB-2 product expression and response to endocrine therapy in advanced breast cancer. Br J Cancer 65:118-121
38. Arnold SF, Obourn JD, Jaffe H, Notides AC 1995 Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding. J Steroid Biochem Mol Biol 55:163-172
39. Martin MB, Garcia-Morales P, Stoica A, Solomon HB, Katz D, Zhang S, Danielson M, Saceda M 1995 Effects of 12-O-tetradecanoylphorbol-13-acetate on estrogen receptor activity in MCF-7 cells. J Biol Chem 270:25244-25251
40. Kraus MH, Popescu NC, Amsbaugh S, King CR 1987 Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6:605-610
41. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione JA, Vandlen RL, Carraway KL 1994 Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269:14661-14665
42. Culouscou JM, Plowman GD, Carlton GW, Green JM, Shoyab M 1993 Characterization of a breast cancer cell differentiation factor that specifically activates the HER4/p180erbB4 receptor. J Biol Chem 268:18407-18410
43. Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker M, Sliwkowski MX, Slamon DJ 1995 HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10:2435-2446
44. Read LD, Keith Jr D, Slamon DJ, Katzenellenbogen BS 1990 Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. Cancer Res 50: 3947-3951